Relation between 90K and initial patient characteristics
Variable . | N* . | 90K levels . | |
---|---|---|---|
High (%)† . | P . | ||
All patients | 137 | 39 (28) | |
Age (years) | |||
≤54 | 71 | 22 (31) | |
>54 | 66 | 17 (26) | .24 |
Gender | |||
Male | 77 | 20 (26) | |
Female | 60 | 19 (32) | .72 |
Lactate dehydrogenase (U/l) | |||
≤284 | 62 | 14 (22) | |
>284 | 68 | 22 (32) | .45 |
Histologic subtype | |||
B cell | |||
DLCL | 59 | 17 (29) | |
FL | 26 | 6 (23) | |
IM | 6 | 3 (50) | |
MCL | 5 | 2 (40) | |
T cell | |||
LL | 9 | 4 (44) | .13 |
Peripheral T-cell lymphoma | 7 | 2 (28) | |
Anaplastic T-cell lymphoma | 4 | 2 (50) | |
Ann Arbor stage | |||
I | 18 | 7 (39) | |
II | 21 | 5 (24) | |
III | 33 | 9 (27) | .28 |
IV | 56 | 17 (30) | |
Bone marrow involvement | |||
Yes | 35 | 14 (40) | |
No | 85 | 22 (26) | .06 |
Bulky disease | |||
Yes | 28 | 6 (21) | |
No | 100 | 32 (32) | .14 |
Variable . | N* . | 90K levels . | |
---|---|---|---|
High (%)† . | P . | ||
All patients | 137 | 39 (28) | |
Age (years) | |||
≤54 | 71 | 22 (31) | |
>54 | 66 | 17 (26) | .24 |
Gender | |||
Male | 77 | 20 (26) | |
Female | 60 | 19 (32) | .72 |
Lactate dehydrogenase (U/l) | |||
≤284 | 62 | 14 (22) | |
>284 | 68 | 22 (32) | .45 |
Histologic subtype | |||
B cell | |||
DLCL | 59 | 17 (29) | |
FL | 26 | 6 (23) | |
IM | 6 | 3 (50) | |
MCL | 5 | 2 (40) | |
T cell | |||
LL | 9 | 4 (44) | .13 |
Peripheral T-cell lymphoma | 7 | 2 (28) | |
Anaplastic T-cell lymphoma | 4 | 2 (50) | |
Ann Arbor stage | |||
I | 18 | 7 (39) | |
II | 21 | 5 (24) | |
III | 33 | 9 (27) | .28 |
IV | 56 | 17 (30) | |
Bone marrow involvement | |||
Yes | 35 | 14 (40) | |
No | 85 | 22 (26) | .06 |
Bulky disease | |||
Yes | 28 | 6 (21) | |
No | 100 | 32 (32) | .14 |
DLCL indicates diffuse large-cell lymphoma, 59 patients; FL, follicular lymphoma, 26 patients; IM, immunocytoma; 6 patients; MCL, mantle-cell lymphoma, 5 patients; LL, lymphoblastic lymphoma, 9 patients.
Information on all variables was not always available.
Number (percentage) of patients with 90K levels above the cutoff value of 13.5 μg/mL.